Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs (French, HTML)
Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs: French HTML file. From Health Canada, updated Jun 2022. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2022-06-07
This guidance document applies to all biologic drug submissions where the sponsor seeks authorization for sale based on demonstrated similarity to a previously approved biologic drug and relies, in part, on prior information regarding that biologic drug in order to present a reduced clinical and non-clinical package as part of the submission.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file